Trillion virion delay -: Time from testing positive for HIV to presentation for primary care

被引:148
作者
Samet, JH
Freedberg, KA
Stein, MD
Lewis, R
Savetsky, J
Sullivan, L
Levenson, SM
Hingson, R
机构
[1] Boston Univ, Sch Med & Publ Hlth, Dept Med, Gen Internal Med Sect, Boston, MA 02118 USA
[2] Boston Univ, Sch Med & Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA
[3] Boston Univ, Sch Med & Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
关键词
D O I
10.1001/archinte.158.7.734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Human immunodeficiency virus (HIV)infected individuals' initial presentation to medical care frequently occurs at a point of advanced immunosuppression. Objectives: To investigate the time between HIV testing and presentation to primary care. Also to examine factors associated with delayed presentation. Methods: One hundred eighty-nine consecutive outpatients without prior primary care for HIV infection were assessed at 2 urban hospitals: Boston City Hospital, Boston, Mass, and Rhode Island Hospital, Providence. Sociodemographics, alcohol and drug use, social support, sexual beliefs and practices, and HIV testing issues were examined in bivariate and multivariate analyses for association with delay in presentation to primary care after positive test results for HIV. Results: Of 189 patients, 74 (39%) delayed seeking primary care for more than 1 year, 61 (32%) delayed for more than 2 years, and 35 (18%) for more than 5 years after an initial positive HIV serologic evaluation. The median CD4(+) cell count of subjects was 0.28 x 10(9)/L (range, 0.001-1.71 x 10(9)/L). In multiple linear regression analysis the following characteristics were found to be associated with delayed presentation to primary care after HIV testing: history of injection drug use (P < .001); not having a living mother (P = .01); not having a spouse or partner (P = .08); not being aware of HIV risk before testing (P < .001); and being notified of HIV status by mail or telephone (P = .002). An interaction effect between sex and screening for alcohol abuse was significant (P = .03) and suggested longer delays for men with positive screening test results (CAGE [an alcoholism screening questionnaire containing 4 structured questions], 2+) compared with men without positive screening test results or women. Conclusions: Patients with positive HIV test results often delay for more than a year before establishing primary medical care. Information readily available at the time of HIV testing concerning substance abuse, social support, and awareness of personal HIV risk status is useful in identifying patients who are at high risk of not linking with primary care. Patients who were notified of their HIV status by mail or telephone delayed considerably longer than those notified in person. Efforts to ensure primary care linkage at the time of notification of positive HIV serostatus are necessary to maximize benefits for both individual and public health and should be an explicit task of posttest counseling.
引用
收藏
页码:734 / 740
页数:7
相关论文
共 22 条
[1]   EFFECTS OF DISEASE STAGE AND ZIDOVUDINE THERAPY ON THE DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN SEMEN [J].
ANDERSON, DJ ;
OBRIEN, TR ;
POLITCH, JA ;
MARTINEZ, A ;
SEAGE, GR ;
PADIAN, N ;
HORSBURGH, CR ;
MAYER, KH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (20) :2769-2774
[2]  
[Anonymous], 1993, MMWR Recomm Rep, V42, P11
[3]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[4]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P1
[5]  
*CDCP, 1996, MMWR-MORBID MORTAL W, V8, P32
[6]  
Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P2
[7]   THE RISK OF DETERMINING RISK WITH MULTIVARIABLE MODELS [J].
CONCATO, J ;
FEINSTEIN, AR ;
HOLFORD, TR .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) :201-210
[8]  
DESPREZ RM, 1985, PRINCIPLES PRACTICE, P1384
[9]   TREATMENT WITH LAMIVUDINE, ZIDOVUDINE, OR BOTH IN HIV-POSITIVE PATIENTS WITH 200 TO 500 CD4+ CELLS PER CUBIC MILLIMETER [J].
ERON, JJ ;
BENOIT, SL ;
JEMSEK, J ;
MACARTHUR, RD ;
SANTANA, J ;
QUINN, JB ;
KURITZKES, DR ;
FALLON, MA ;
RUBIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1662-1669
[10]   EPIDEMIOLOGY OF LATE PRESENTATION OF HIV-INFECTION IN WESTERN AUSTRALIA [J].
GILLIEATT, SJ ;
MALLAL, SA ;
FRENCH, MAH ;
DAWKINS, RL .
MEDICAL JOURNAL OF AUSTRALIA, 1992, 157 (02) :117-118